Forensic scientists. 25 years. One mission.
DrugLab118 grew out of forensic laboratory science into a global mission: to make instant drug detection visible, normal, and accessible wherever people gather. It is led by named scientists and advocates with the credentials to back every claim we make.
The longest-established authority in instant drug detection
DrugLab118 was the first company to commercialise rapid drink-spiking tests built on laboratory-validated forensic methodologies. We have been developing detection technology since 2003 — longer than any competitor operating in this market today.
The company evolved from earlier forensic innovation work into the focused business it is now: Drug Lab 118 Ltd, dedicated entirely to making instant detection part of everyday social safety.
Our detection chemistry is developed and produced in Great Britain by SureScreen Diagnostics in Derby — the laboratory founded by our Chief Scientific Officer, Jim Campbell, the named inventor on the DRUGLAB test. From there, tests are assembled into their many formats for markets around the world.
Today the team is small, senior, and deliberately international, drawing on a wider network of forensic, commercial, and safety specialists as each project requires.
Named leaders. Real credentials.
Scientific authority and behavioural insight, combined.
Colin Lyon
Building safer social spaces — women's safety, behavioural risk & harm prevention.
Colin works at the intersection of emerging social risk, behavioural psychology, and real-world safety. He founded DrugLab118 on the conviction that detection technology is only half the answer — the other half is changing behaviour.
Online spaces have enabled the rapid scaling of misogyny-centred belief systems. These are not abstract cultural issues; they are behavioural conditioning systems that lower the psychological barriers to harassment, coercion, and sexual violence across social environments — from nightlife to university campuses. Colin's focus is on reversing that trajectory by moving upstream — addressing not just incidents, but the systems and behaviours that enable them:
- Empowerment — giving individuals, particularly women, the tools and agency to protect themselves.
- Personal responsibility — challenging entitlement and normalised harmful behaviour.
- Collective accountability — working with institutions, communities, and organisations to shift norms and reduce risk.
Jim Campbell is a former Home Office Forensic Scientist with over thirty years' experience, trained as an analytical chemist and toxicologist in criminalistics and drug abuse. His expertise spans toxicology, drug and alcohol casework, drug and precursor detection and analysis, and forensic scenes of crime including arson and accident reconstruction. He regularly handles drug analysis for the criminal courts.
Through his laboratory, SureScreen Diagnostics, Jim has researched and resourced tests for conditions including Hepatitis, HIV, and BSE, as well as drug screening from hair analysis. He holds patents in biopsy tissue sampling and in a nanotechnology capable of uniquely identifying traces of drugs, poisons, and pesticides, and is a joint patent holder for the analysis of hair to identify alcohol misuse.
Jim is the named inventor on the DRUGLAB drug-detection test and is the primary scientific lead on every DrugLab118 development.
Jim Campbell
Former Home Office Forensic Scientist · 30+ years · named inventor on the DRUGLAB test.
Seymour Ferreira
Commercial leadership · global drinks & consumer goods · brand-building.
A former Executive Director of Green Cola PLC — an Athens-based healthy soft-drink company — and Group CEO of Amber Beverage Group, a multinational farm-to-retail adult-beverage company headquartered in Luxembourg.
Seymour brings extensive international consumer-goods experience scaling brands and businesses across Asia Pacific, the Middle East and Europe, gained over a career with Diageo, Allied Domecq, Absolut and Edrington. He is concurrently Chairman of Ridgeview Wines (UK) and Edmunds Cocktails (UK), and CEO of Chimera Brand Development (UK).
Share the mission. Build the infrastructure.
We invite organisations and partners who share this vision to work with us — to build the detection, education, and culture that make safety normal.
Request a Briefing →